DEA ALJ Rejects Challenges to Placing DOI, DOC in Schedule I

Oops! Subscribers must be logged in to access this content.

Not A Controlled Substances’ Subscriber?

Unlock access to the benefits below with a no-cost, risk-free trial of the Controlled Substances Module.

Subscription Benefits

Start Your Free Trial

By signing up for a tour of the Thompson Controlled Substances Module, you are also registering to receive email offers and product updates from us. Simply click unsubscribe at the bottom of any email if you would like to discontinue delivery.

DEA ALJ Rejects Challenges Brought by Researchers Against Proposal To Add DOI, DOC to Schedule I

Dennis Tosh

June 28, 2025 at 17:21:19 ET

A DEA administrative law judge (ALJ) has rejected challenges brought against an agency proposal to schedule two psychedelic drugs in Schedule I (In re Schedules of Controlled Substances: Placement of 2,5-dimethoxy-4- iodoamphetamine (DOI) and 2,5- dimethoxy-4-chloroamphetamine (DOC) in Schedule I, No. 24-24 (DEA June 20, 2025)). In December 2023, the DEA proposed placing the two su... Read More

My Research Folders

You are not Logged in yet, Please login to see Your research folders.

Oops! Subscribers must be logged in to access this content.

Not A Controlled Substances’ Subscriber?

Unlock access to the benefits below with a no-cost, risk-free trial of the Controlled Substances Module.

Subscription Benefits

Start Your Free Trial

DEA ALJ Rejects Challenges Brought by Researchers Against Proposal To Add DOI, DOC to Schedule I

My Research Folders

THOMPSON CONTROLLED SUBSTANCES

COMPLIANCE EXPERT

DEA RESOURCES

HELP

CONTACT